Transform and Release have produced a joint briefing paper on the UK government’s proposed Psychoactive Substances Bill, which goes for its second reading in the House of Lords tomorrow.
Our briefing analyses the Bill, highlighting its significant flaws and recommending that the legislative process behind it be postponed for the following reasons:
- To allow for formal public consultation as outlined in the Cabinet Office’s Consultation Principles.
- So that the ACMD can be fully consulted on all aspects of the proposed legislation before either House considers this legislation.
- In order to consider more effective alternatives.
In fact, we are of the view that the issue of NPS should not be seen in isolation and that this provides an opportunity to consider the evidence for alternative approaches to all substances currently controlled by the MDA and those emerging NPS not currently controlled.